This analysis uncovers the evolutionary trajectory of lung adenocarcinoma in Chinese patients, highlighting various mutational signatures and periods.
The proportion of different mutational signatures that underlie Kataegis over different mutation periods.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: